The FDA Approves New Treatment for Chronic Lymphocytic Leukemia Under an International Program
source: pixabay.com

The FDA Approves New Treatment for Chronic Lymphocytic Leukemia Under an International Program

According to a story from PR Newswire, the US Food and Drug Administration (FDA) has recently granted supplemental approval to the drug acalabrutinib (marketed as Calquence) as a treatment for…

Continue Reading The FDA Approves New Treatment for Chronic Lymphocytic Leukemia Under an International Program
OTL-200 Granted Accelerated Assessment for Treatment of Metachromatic Leukodystrophy (MLD)
source: pixabay.com

OTL-200 Granted Accelerated Assessment for Treatment of Metachromatic Leukodystrophy (MLD)

  The development of treatments and medicines for diseases can take a long time. These treatments come from many hours of research, studies, trials, and waiting for approval from the…

Continue Reading OTL-200 Granted Accelerated Assessment for Treatment of Metachromatic Leukodystrophy (MLD)
These Two Companies Just Announced a Partnership to Develop Multiple Gene Therapies
EliasSch / Pixabay

These Two Companies Just Announced a Partnership to Develop Multiple Gene Therapies

According to a story from BioSpace, the gene therapy companies Sarepta Therapeutics, Inc. and StrideBio, Inc. have recently announced the completion of a licensing and collaboration agreement that could lead…

Continue Reading These Two Companies Just Announced a Partnership to Develop Multiple Gene Therapies
This Treatment for Multiple Sclerosis Could be on its Way to Approval in the EU
source: pixabay.com

This Treatment for Multiple Sclerosis Could be on its Way to Approval in the EU

According to a story from finanznachricten.de, the drug company Novartis recently announced that the European Medicine Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive…

Continue Reading This Treatment for Multiple Sclerosis Could be on its Way to Approval in the EU
An Experimental Treatment for Rett Syndrome Earns Rare Pediatric Disease Designation
source: pixabay.com

An Experimental Treatment for Rett Syndrome Earns Rare Pediatric Disease Designation

According to a story from marketscreener.com, the biopharmaceutical company Anavex Life Sciences Corp. has announced that its experimental product candidate ANAVEX2-73 has earned Rare Pediatric Disease designation from the US…

Continue Reading An Experimental Treatment for Rett Syndrome Earns Rare Pediatric Disease Designation

Breakthrough Therapy Designation Given to Investigative WHIM Syndrome Treatment

WHIM Syndrome WHIM syndrome is a form of primary immunodeficiency. It is caused by a mutation in the CXCR4 gene. WHIM stands for Warts, Hypogammaglobulinemia, Infections, and Myelokathexis. Throughout their…

Continue Reading Breakthrough Therapy Designation Given to Investigative WHIM Syndrome Treatment

PID Patients Could Receive More Personalized Treatment Thanks to New Study

A New Study A recent study published in Nature Immunology and conducted by researchers at the University of Basel has produced influential results regarding primary immunodeficiency disorders (PID). These rare disorders…

Continue Reading PID Patients Could Receive More Personalized Treatment Thanks to New Study
CBD-Based Treatment for Rare Childhood Epilepsies Gets Recommendation from NICE
source: pixabay.com

CBD-Based Treatment for Rare Childhood Epilepsies Gets Recommendation from NICE

According to a story from BioPortfolio, the biopharmaceutical company GW Pharmaceuticals plc recently announced that its medicine Epidyolex has earned recommendation from the UK National Institute for Health and Care…

Continue Reading CBD-Based Treatment for Rare Childhood Epilepsies Gets Recommendation from NICE
Health Canada Approves Cabometyx for Previously Treated Hepatocellular Carcinoma
ArtTower / Pixabay

Health Canada Approves Cabometyx for Previously Treated Hepatocellular Carcinoma

According to a story from the Malvern Daily Record, the biotechnology company Exelixis, Inc. has recently announced that its partner company Ipsen BioPharmaceuticals Canada Inc. has had its drug cabozantinib…

Continue Reading Health Canada Approves Cabometyx for Previously Treated Hepatocellular Carcinoma